Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-05-21FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for amlodipine besylate (generic) under ANDA 078043.
-
FDA approval · 2018-05-21FDA Approved: NIFEDIPINE — Supplemental Application (Leading Pharma, LLC)
FDA approved a supplemental application for nifedipine submitted by Leading Pharma, LLC.
-
FDA approval · 2018-05-21FDA Approved: NIFEDIPINE — Supplemental Application (Leading Pharma, LLC)
The FDA approved a supplemental application for nifedipine submitted by Leading Pharma, LLC.
-
FDA approval · 2018-05-07FDA Approved: CARVEDILOL PHOSPHATE — Original Application (AvKARE)
FDA approved AvKARE's Carvedilol Phosphate as a generic original application, granting market approval for this salt form of carvedilol.
-
FDA approval · 2018-05-04FDA Approved: VALSARTAN — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approves the original (generic) application for valsartan from Unichem Pharmaceuticals (USA), Inc., making a generic valsartan product a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-04-26FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Epic Pharma, LLC)
The FDA approved a supplemental application for the generic drug amlodipine besylate submitted by Epic Pharma, LLC. This represents authoriz…
-
FDA approval · 2018-04-26FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for amlodipine besylate submitted by Unichem Pharmaceuticals (USA), Inc., under ANDA 203245. This co…
-
FDA approval · 2018-04-23FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (ACI Healthcare USA, Inc.)
FDA approved a supplemental application for amlodipine besylate (generic) filed by ACI Healthcare USA, Inc., supporting continued marketing …
-
FDA approval · 2018-04-23FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Exelan Pharmaceuticals, Inc.)
FDA approved a supplemental application for amlodipine besylate from Exelan Pharmaceuticals, Inc., approving a generic product.
-
FDA approval · 2018-04-23FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (POLYGEN PHARMACEUTICALS INC.)
FDA approved a supplemental application for amlodipine besylate from PolyGen Pharmaceuticals, approving a generic version.
-
FDA approval · 2018-04-20FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s supplemental application for amlodipine besylate under ANDA077073.
-
FDA approval · 2018-04-19FDA Approved: THALITONE — Supplemental Application (Casper Pharma LLC)
FDA approved a supplemental application for THALITONE (chlorthalidone) submitted by Casper Pharma LLC.
-
FDA approval · 2018-04-17FDA Approved: DOXAZOSIN — Original Application (Upsher-Smith laboratories, LLC)
The FDA granted approval of Upsher-Smith's original application for doxazosin mesylate, making doxazosin available as a generic product. Dox…
-
FDA approval · 2018-04-17FDA Approved: IRBESARTAN — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's original application for irbesartan (IRBESARTAN), enabling a generic version of the antihypertensive medication.
-
FDA approval · 2018-04-11FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Original Application (Solco Healthcare LLC)
FDA approved a generic fixed-dose combination of candesartan cilexetil and hydrochlorothiazide for hypertension under an Original Applicatio…
-
FDA approval · 2018-04-09FDA Approved: VALSARTAN — Original Application (SQUARE PHARMACEUTICALS LIMITED)
The FDA approved Square Pharmaceuticals Limited's original application for valsartan (generic valsartan).
-
FDA approval · 2018-04-02FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (PD-Rx Pharmaceuticals, Inc.)
FDA approved a supplemental application for amlodipine besylate filed by PD-Rx Pharmaceuticals, Inc. The action concerns a supplemental appr…
-
FDA approval · 2018-04-02FDA Approved: AMLODIPINE BESYLATE 2.5 MG — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approves a supplemental application to add a 2.5 mg strength of amlodipine besylate (generic) manufactured by Oxford Pharmaceuticals, ex…
-
FDA approval · 2018-03-23FDA Approved: METOPROLOL SUCCINATE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the original application for METOPROLOL SUCCINATE (generic) from Zydus Pharmaceuticals (USA) Inc., authorizing its marketing as…
-
FDA approval · 2018-03-14FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva's supplemental application for amlodipine besylate, enabling the marketing of a generic version of the antihypertensive/an…
-
FDA approval · 2018-03-14FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved the Supplemental Application for Aurobindo Pharma Limited to market amlodipine besylate as a generic formulation.
-
FDA approval · 2018-03-14FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for amlodipine besylate filed by Zydus Pharmaceuticals USA Inc. The action confirms approval of …
-
FDA approval · 2018-02-13FDA Approved: DOXAZOSIN — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original application for doxazosin (generic), manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.,…
-
FDA approval · 2018-02-01FDA Approved: MICARDIS HCT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Micardis HCT (telmisartan and hydrochlorothiazide) from Boehringer Ingelheim Pharmaceuticals…
-
FDA approval · 2018-02-01FDA Approved: MICARDIS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Micardis (telmisartan) from Boehringer Ingelheim Pharmaceuticals, Inc. The approval pertains…